NEWS
Free Institutional Consultancy Services
New Feature: Compare Your Institution with the Previous Year
Find a Professional: Explore Experts Across 197 Disciplines in 220 Countries!
Find a Professional
Print Your Certificate
New! Young University / Institution Rankings 2025
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
Highly Cited Researchers 2025
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
login
Login
person_add
Register
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Reports
person
Find a Professional
Sanchaika Gaur
Cedars-Sinai Medical Center - California / United States
Natural Sciences / Molecular Biology & Genetics
AD Scientific Index ID: 4471313
Registration, Add Profile,
Premium Membership
Print Your Certificate
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Subject Leaders
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Sanchaika Gaur's MOST POPULAR ARTICLES
1-)
Epigenetic silencing of microRNA-203 is required for EMT and cancer stem cell propertiesJH Taube, GG Malouf, E Lu, N Sphyris, V Vijay, PP Ramachandran, ...Scientific reports 3 (1), 1-10, 20131272013
2-)
Chitosan nanoparticle-mediated delivery of miRNA-34a decreases prostate tumor growth in the bone and its expression induces non-canonical autophagyS Gaur, Y Wen, JH Song, NU Parikh, LS Mangala, AM Blessing, C Ivan, ...Oncotarget 6 (30), 29161, 20151012015
3-)
The role of HGF/c-Met signaling in prostate cancer progression and c-Met inhibitors in clinical trialsA Varkaris, PG Corn, S Gaur, F Dayyani, CJ Logothetis, GE GallickExpert opinion on investigational drugs 20 (12), 1677-1684, 2011862011
4-)
Ligand‐independent activation of MET through IGF‐1/IGF‐1R signalingA Varkaris, S Gaur, NU Parikh, JH Song, F Dayyani, JK Jin, CJ Logothetis, ...International journal of cancer 133 (7), 1536-1546, 2013572013
5-)
Integrating murine and clinical trials with cabozantinib to understand roles of MET and VEGFR2 as targets for growth inhibition of prostate cancerA Varkaris, PG Corn, NU Parikh, E Efstathiou, JH Song, YC Lee, ...Clinical Cancer Research 22 (1), 107-121, 2016522016
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept